Here's the live share price of Aarti Drugs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Aarti Drugs has declined 9.66% CAGR. Over the past year, the corresponding return has been -9.90%.
Aarti Drugs’s current P/E of 19.46x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Aarti Drugs | 10.22 | -1.37 | -18.00 | -3.26 | -9.90 | -1.50 | -9.66 |
| Sun Pharmaceutical Industries | -3.21 | -2.45 | 6.80 | 4.59 | -4.41 | 20.27 | 24.12 |
| Divi's Laboratories | 3.16 | 2.12 | 8.52 | -1.10 | 12.27 | 23.69 | 11.61 |
| Torrent Pharmaceuticals | 1.66 | 3.04 | 5.99 | 20.58 | 12.65 | 34.66 | 22.45 |
| Cipla | -0.09 | -0.55 | -2.74 | -0.48 | 1.34 | 10.91 | 12.41 |
| Dr. Reddy's Laboratories | -0.32 | 3.53 | -2.41 | -5.19 | -6.16 | 14.28 | 4.03 |
| Lupin | -0.34 | 5.37 | 5.77 | 9.08 | -2.87 | 41.56 | 16.62 |
| Zydus Lifesciences | -0.10 | -0.99 | -11.37 | -4.92 | -4.87 | 29.70 | 13.38 |
| Mankind Pharma | 4.19 | -0.96 | -13.08 | -4.75 | -24.46 | 15.58 | 9.07 |
| Aurobindo Pharma | 1.42 | 1.31 | 10.86 | 9.60 | -4.14 | 40.40 | 5.89 |
| Alkem Laboratories | -1.08 | -1.09 | -0.16 | 15.83 | 2.90 | 21.81 | 13.77 |
| Abbott India | 3.45 | -3.72 | -5.10 | -9.18 | 0.54 | 9.56 | 12.70 |
| Laurus Labs | 7.56 | 10.69 | 19.40 | 62.17 | 91.40 | 41.66 | 25.52 |
| Glenmark Pharmaceuticals | 3.41 | 9.40 | -0.18 | 19.75 | 31.11 | 67.86 | 32.33 |
| Biocon | 3.02 | 0.86 | 10.92 | 14.09 | 15.44 | 14.51 | -3.75 |
| GlaxoSmithKline Pharmaceuticals | -3.94 | 0.21 | -9.76 | -23.16 | 9.49 | 23.09 | 10.09 |
| Anthem Biosciences | 0.48 | 5.66 | -18.74 | -8.61 | -8.61 | -2.95 | -1.78 |
| Ipca Laboratories | 1.11 | -0.60 | 4.56 | 5.82 | -10.75 | 18.53 | 5.49 |
| Ajanta Pharma | 4.74 | 8.33 | 7.59 | 6.14 | -2.83 | 32.00 | 19.59 |
| J B Chemicals & Pharmaceuticals | 0.89 | 3.29 | 6.77 | 0.62 | -2.99 | 23.13 | 28.52 |
Over the last one year, Aarti Drugs has declined 9.90% compared to peers like Sun Pharmaceutical Industries (-4.41%), Divi's Laboratories (12.27%), Torrent Pharmaceuticals (12.65%). From a 5 year perspective, Aarti Drugs has underperformed peers relative to Sun Pharmaceutical Industries (24.12%) and Divi's Laboratories (11.61%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 384.15 | 394.6 |
| 10 | 389.18 | 394.73 |
| 20 | 403.26 | 405.82 |
| 50 | 454.29 | 436.76 |
| 100 | 474.48 | 454.49 |
| 200 | 448.45 | 458.78 |
In the latest quarter, Aarti Drugs saw a drop in promoter holding to 54.73%, while DII stake decreased to 9.90%, FII holding rose to 2.68%, and public shareholding moved up to 32.70% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 63,87,722 | 1.6 | 271.38 | |
| 14,53,383 | 0.96 | 61.75 | |
| 8,52,155 | 1.14 | 36.2 | |
| 70,308 | 0.24 | 2.99 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Nov 15, 2025, 12:17 AM IST | Aarti Drugs Ltd - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Nov 11, 2025, 3:52 AM IST | Aarti Drugs Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Nov 08, 2025, 2:15 AM IST | Aarti Drugs Ltd - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Nov 08, 2025, 2:09 AM IST | Aarti Drugs Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Nov 07, 2025, 8:26 PM IST | Aarti Drugs Ltd - Board Meeting Outcome for Financial Results For The Quarter And Half Year Ended September 30, 2025 |
Aarti Drugs Ltd. is a Public Limited Listed company incorporated on 28/09/1984 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L37060MH1984PLC055433 and registration number is 055433. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 2173.65 Cr. and Equity Capital is Rs. 91.27 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Aarti Drugs is ₹424.45 as on Dec 24, 2025.
The Aarti Drugs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Aarti Drugs is ₹3,873.96 Cr as on Dec 24, 2025.
Today’s highest and lowest price of Aarti Drugs are ₹425.00 and ₹404.35.
The 52-week high/low is the highest and lowest price at which Aarti Drugs stock has traded in the past 52-week or nearly a year. The 52-week high of Aarti Drugs is ₹574.95 and 52-week low of Aarti Drugs is ₹312.50 as on Dec 24, 2025.
The Aarti Drugs has shown returns of 2.81% over the past day, -1.37% for the past month, -18.0% over 3 months, -9.9% over 1 year, -1.5% across 3 years, and -9.66% over 5 years.
P/E ratio of and PB ratio of Aarti Drugs are 19.46 and 2.64 on Dec 24, 2025. While the company gives a dividend yield of 0.24 per annum.